🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective is to compare the efficacy and safety of masitinib in combina...
Status
Not Yet Recruiting
Location
Aiginition Hospital
Start Date
2026-01-01
Trial ID
NCT07174492
Treatments Being Tested
The objective is to compare efficacy and safety of masitinib in combination...
Status
Completed
Location
Hospital AZ Sint-Jan
Start Date
2014-07
Trial ID
NCT03766295
Treatments Being Tested
The objective of the study is to evaluate the anti-viral efficacy of 3 diff...
Status
Unknown
Location
Intensive Care Unit, CHU Gabriel-Montpied
Start Date
2021-11-23
Trial ID
NCT05047783
Treatments Being Tested
The objective is to compare the efficacy and safety of masitinib in combina...
Status
Completed
Location
Hospital Carlos III
Start Date
2013-04
Trial ID
NCT02588677
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of masitinib...
Status
Completed
Location
MHAT Sveta Marina
Start Date
2012-01
Trial ID
NCT01872598
Treatments Being Tested
The purpose of this study is to evaluate the activity of oral AB1010, admin...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT01450488
This phase 2 study was designed to evaluate the activity of oral masitinib ...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00976118
Treatments Being Tested
The objective of this study is to compare the efficacy and safety of masiti...
Status
Completed
Location
Eastern Connecticut Hematology and Oncology (ECHO)
Start Date
2008-11-25
Trial ID
NCT00789633
Treatments Being Tested
The objective is to compare the efficacy and safety of masitinib at 4.5 mg/...
Status
Terminated
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02009423
To evaluate the efficacy and safety of oral masitinib versus placebo in the...
Status
Suspended
Location
Service de Neurologie Hôpital Henri-Mondor
Start Date
2022-06-28
Trial ID
NCT05441488
Treatments Being Tested